{
    "Rank": 276,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00848289",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "LAB98-040"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "LAB98-040",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "MD Anderson Cancer Center"
                        },
                        {
                            "SecondaryId": "5P50CA091846-14",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/5P50CA091846-14"
                        },
                        {
                            "SecondaryId": "H-8577",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "Baylor College of Medicine"
                        },
                        {
                            "SecondaryId": "5R01CA074880",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/5R01CA074880"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "M.D. Anderson Cancer Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Genetic Susceptibility to Bladder Cancer",
                "OfficialTitle": "Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach"
            },
            "StatusModule": {
                "StatusVerifiedDate": "August 2023",
                "OverallStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "February 10, 1998",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "August 1, 2024",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "August 2024",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "February 19, 2009",
                "StudyFirstSubmitQCDate": "February 19, 2009",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "February 20, 2009",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "August 14, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "August 15, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "M.D. Anderson Cancer Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "National Cancer Institute (NCI)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "This clinical research study will identify biologic and lifestyle factors which increase a person's risk of developing specific cancer. Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibility to tobacco carcinogenesis and this will include studies of the genetic modulation of carcinogen activation and detoxification and of chromosome sensitivity to tobacco mutagens.",
                "DetailedDescription": "Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibility to tobacco carcinogenesis and this will include studies of the genetic modulation of carcinogen activation and detoxification and of chromosome sensitivity to tobacco mutagens."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Bladder Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Bladder cancer",
                        "Genetic susceptibility",
                        "Increased Risk"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Other"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples Without DNA",
                    "BioSpecDescription": "blood (about 40 cc or 8 teaspoons), urine"
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "4500",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Participants with Bladder Cancer",
                            "ArmGroupDescription": "Patients diagnosed with superficial or muscle-invasive bladder cancer. Specimens, personal and follow-up telephone interviews will be collected and conducted.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Behavioral: Interviews"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Behavioral",
                            "InterventionName": "Interviews",
                            "InterventionDescription": "Data collected by personal interview for Epidemiology and Nutrition Questionnaires, with personal and follow-up telephone interviews.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Participants with Bladder Cancer"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Comparison of mutagen sensitivity susceptibility assays that quantifies the number of lymphocytic chromatid breaks induced by in vitro exposure to bleomycin and the number of breaks induced by in vitro exposure to a tobacco carcinogen",
                            "PrimaryOutcomeDescription": "Mutagen sensitivity as measured by quantifying the number of lymphocytic chromatid breaks and comet tail moments induced by in vitro exposure to bleomycin (a radiomimetic agent) and benzo[a]pyrene diol epoxide (BPDE, a tobacco carcinogen) in bladder cancer cases in comparison to data for controls",
                            "PrimaryOutcomeTimeFrame": "After last subject has completed the study, up to 5 years"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Frequencies of polymorphisms in those genes that regulate the metabolism of carcinogens in tobacco smoke",
                            "SecondaryOutcomeTimeFrame": "After the last subject completes the study, up to 5 years"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Associations between the cytogenetic, molecular components and epidemiologic covariates (age, sex, ethnicity, cigarette smoking status, alcohol use, dietary intake, and family history of cancer) in risk of bladder cancer",
                            "SecondaryOutcomeTimeFrame": "After the last subject has completed the study, up to 5 years per individual participation"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nSubject has a histologically confirmed diagnosis of superficial or muscle-invasive bladder cancer\nSubject is a Texas resident.\nSubject can understand English or a qualified translator is available for the interview.\nSubjects of any age, gender, or ethnicity are eligible to participate in the study.\nSubject consents to participate in the study.\n\nExclusion Criteria:\n\nSubject has had prior treatment with systemic chemotherapy or radiotherapy in the past 6 months.\nSubject has been diagnosed with superficial or muscle-invasive bladder cancer more than twelve months ago.",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "All",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Any patient who have been diagnosed with bladder cancer or who is healthy is eligible to participate without regard to age, sex, or ethnicity.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Jian Gu, MD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "713-792-3020",
                            "CentralContactEMail": "jiangu@mdanderson.org"
                        },
                        {
                            "CentralContactName": "Tao T Le, Program Director, Epidemiology",
                            "CentralContactRole": "Contact",
                            "CentralContactEMail": "tle@mdanderson.org"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Jian Gu, MD",
                            "OverallOfficialAffiliation": "M.D. Anderson Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Baylor College of Medicine",
                            "LocationStatus": "Terminated",
                            "LocationCity": "Houston",
                            "LocationState": "Texas",
                            "LocationZip": "77030",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "MD Anderson Cancer Center",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Houston",
                            "LocationState": "Texas",
                            "LocationZip": "77030",
                            "LocationCountry": "United States",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Jian Gu, PhD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactPhone": "713-792-8016",
                                        "LocationContactEMail": "jiangu@mdanderson.org"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "SeeAlsoLinkList": {
                    "SeeAlsoLink": [
                        {
                            "SeeAlsoLinkLabel": "The University of Texas (UT) MD Anderson Cancer Center Official Website",
                            "SeeAlsoLinkURL": "http://www.mdanderson.org"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001749",
                            "ConditionMeshTerm": "Urinary Bladder Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000004198",
                            "ConditionMeshTerm": "Disease Susceptibility"
                        },
                        {
                            "ConditionMeshId": "D000020022",
                            "ConditionMeshTerm": "Genetic Predisposition to Disease"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000014571",
                            "ConditionAncestorTerm": "Urologic Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000001745",
                            "ConditionAncestorTerm": "Urinary Bladder Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000014570",
                            "ConditionAncestorTerm": "Urologic Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000052801",
                            "ConditionAncestorTerm": "Male Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000020969",
                            "ConditionAncestorTerm": "Disease Attributes"
                        },
                        {
                            "ConditionAncestorId": "D000010335",
                            "ConditionAncestorTerm": "Pathologic Processes"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4720",
                            "ConditionBrowseLeafName": "Urinary Bladder Neoplasms",
                            "ConditionBrowseLeafAsFound": "Bladder Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M7070",
                            "ConditionBrowseLeafName": "Disease Susceptibility",
                            "ConditionBrowseLeafAsFound": "Susceptibility",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M21565",
                            "ConditionBrowseLeafName": "Genetic Predisposition to Disease",
                            "ConditionBrowseLeafAsFound": "Genetic Susceptibility",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M17010",
                            "ConditionBrowseLeafName": "Urologic Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M4716",
                            "ConditionBrowseLeafName": "Urinary Bladder Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17009",
                            "ConditionBrowseLeafName": "Urologic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26785",
                            "ConditionBrowseLeafName": "Male Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M22390",
                            "ConditionBrowseLeafName": "Disease Attributes",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        }
                    ]
                }
            }
        }
    }
}